Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 9 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 7728004

    Crystalline form of a quinolinone-carboxamide compound

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  2. US 7723470

    Glycopeptide derivatives and pharmaceutical compositions containing the same

    Theravance, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted

  3. US 7713931

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted May 11, 2010 · Expires May 6, 2030

    granted

  4. US 7700777

    Crystalline forms of a biphenyl compound

    Theravance, Inc. · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted

  5. US 7700550

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted

  6. US 7691878

    Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted

  7. US 7687519

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted

  8. US 7687521

    Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted

  9. US 7683173

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted

  10. US 7674908

    Indazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted

  11. US 7671198

    Process for preparing intermediates to 5-HT4 receptor agonist compounds

    Theravance, Inc. · Granted Mar 2, 2010 · Expires Feb 25, 2030

    granted

  12. US 7662815

    Diaryl ether β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  13. US 7659403

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  14. US 7655621

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted

  15. US 7649080

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jan 19, 2010 · Expires Jan 14, 2030

    granted

  16. US 7642355

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  17. US 7638639

    Substituted pyrrolidine and related compounds

    Theravance, Inc. · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  18. US 7632847

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  19. US 7629336

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted

  20. US 7622587

    Crystalline form of a benzimidazole-carboxamide medicinal compound

    Theravance, Inc. · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  21. US 7622508

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  22. US 7622467

    Aryl aniline derivatives as β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  23. US 7615566

    Substituted pyrrolidine and related compounds

    Theravance, Inc. · Granted Nov 10, 2009 · Expires Nov 5, 2029

    granted

  24. US 7612037

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.